跳至主要内容
临床试验/DRKS00006354
DRKS00006354已完成不适用

ong-term stability after Class II treatment with the Herbst appliance - Long-term stability Herbst treatment

Justus-Liebig-Universität GiessenPoliklinik für Kieferorthopädie0 个研究点目标入组 72 人开始时间: 2014年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Herbst patients: Orthodontic Herbst appliance treatment as well as subsequent multibracket appliance treatment, treatment completed at least 15 years ago, pre-treatment overjet = 6mm and Class II molar relationship = 0,5 cusp widths (bilaterally) / 1,0 cusp widths (unilaterally)
  • Control group: Class I occlusion, no orthodontic treatment, observation period of at least 15 years (documentation by orthodontic study models)

排除标准

  • Failure of inclusion criteria, incomplete treatment records

研究者

发起方
Justus-Liebig-Universität GiessenPoliklinik für Kieferorthopädie

相似试验

已完成
不适用
ong-term stability after Class II treatment with the Herbst appliance after the end of growthClass II malocclusion (long-term stability after treatment)K07Dentofacial anomalies [including malocclusion]
DRKS00023022Justus-Liebig-Universität Giessen Poliklinik für Kieferorthopädie33
招募中
1 期
ong-Term Follow-Up of Subjects Treated With NTLA-2001-Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN)-Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)MedDRA version: 20.0Level: PTClassification code: 10019889Term: Hereditary neuropathic amyloidosis Class: 100000004850MedDRA version: 20.0Level: PTClassification code: 10007509Term: Cardiac amyloidosis Class: 100000004849
CTIS2023-507385-11-00Intellia Therapeutics Inc.72
招募中
1 期
ong-Term Follow-Up of Subjects Treated With NTLA-2002MedDRA version: 20.0Level: PTClassification code: 10019860Term: Hereditary angioedema Class: 100000004850Hereditary Angioedema
CTIS2023-507956-56-00Intellia Therapeutics Inc.29
进行中(未招募)
1 期
Maintenance therapy with Trabectedin after combination therapy Liposomal Doxorubicin plus Trabectedin vs Liposomal Doxorubicin plus Trabectedin in patients affected by relapsed ovarian cancer.MedDRA version: 21.0Level: PTClassification code 10033160Term: Ovarian epithelial cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Ovarian cancer
EUCTR2017-000987-14-ITAZIENDA OSPEDALIERA PER L'EMERGENZA CANNIZZARO130
尚未招募
不适用
The effectiveness of Forsus FRD appliance in cases with backwardly positioned lower jaw
CTRI/2021/06/034031Sumitra Reddy